N-Acetylcysteine (NAC): Uses and Dosages
N-acetylcysteine (NAC) is primarily used as an antidote for acetaminophen overdose and as a mucolytic agent, with specific FDA-approved dosing regimens for each indication. 1, 2
Acetaminophen Overdose Treatment
Oral Administration Protocol
- Loading dose: 140 mg/kg body weight 1, 2
- First maintenance dose: 70 mg/kg given 4 hours after loading dose 2
- Subsequent maintenance doses: 70 mg/kg every 4 hours for a total of 17 doses 1, 2
Intravenous Administration Protocol
- Loading dose: 150 mg/kg over 15-60 minutes 1
- First maintenance dose: 50 mg/kg over 4 hours 1
- Second maintenance dose: 100 mg/kg over 16 hours 1
Key Clinical Considerations for Acetaminophen Overdose
- Treatment should be initiated as soon as possible, ideally within 8 hours of ingestion, but can be beneficial up to 24 hours post-ingestion 3
- For massive overdose (>30g or >500 mg/kg), consider increased NAC dosing beyond standard protocol if evidence of ongoing liver injury persists 1
- The oral NAC protocol may preserve more hepatocytes than the 21-hour IV protocol for patients presenting within 24 hours of ingestion 4
- Monitor for NAC-related adverse effects, particularly hypersensitivity reactions (10-15% of patients) 1
- Continue NAC treatment until:
- Acetaminophen levels are undetectable
- Liver enzymes are decreasing
- PT/INR is improving
- Patient is clinically improving
Mucolytic Therapy
Nebulization (Face Mask, Mouthpiece, Tracheostomy)
- 1-10 mL of 20% solution or 2-20 mL of 10% solution every 2-6 hours 2
- Recommended dose: 3-5 mL of 20% solution or 6-10 mL of 10% solution 3-4 times daily 2
Direct Instillation
- 1-2 mL of 10-20% solution as often as every hour 2
- For tracheostomy care: 1-2 mL of 10-20% solution every 1-4 hours 2
Diagnostic Bronchograms
- 2-3 administrations of 1-2 mL of 20% solution or 2-4 mL of 10% solution by nebulization or intratracheal instillation prior to procedure 2
Adverse Effects and Precautions
Common Adverse Effects
- Oral administration: Nausea, vomiting, gastrointestinal symptoms 2
- IV administration: Hypersensitivity reactions, anaphylaxis (10-15% of patients) 1
- Nebulization: Stomatitis, rhinorrhea, drowsiness, chest tightness, bronchospasm 2
Monitoring and Management
- For IV administration, monitor for hypersensitivity reactions; manage with temporary discontinuation, antihistamines, and slower infusion rate when restarting 1
- For oral administration in acetaminophen overdose, dilution minimizes the propensity to aggravate vomiting 2
- NAC solution does not contain antimicrobial agents; unused portions should be refrigerated and used within 96 hours 2
Special Considerations
- NAC is pregnancy category B; no evidence of teratogenic effects in animal studies 2
- For patients with hepatic encephalopathy, consider discontinuing NAC to avoid further administration of nitrogenous substances 2
- Patients at risk of gastric hemorrhage should be evaluated for risk versus benefit of oral NAC treatment 2
- Certain materials (notably iron, copper, and rubber) react with NAC; use equipment made of glass, plastic, aluminum, anodized aluminum, chromed metal, tantalum, sterling silver, or stainless steel 2
Emerging Uses
While not FDA-approved for these indications, NAC has shown potential benefit in:
- Chronic obstructive pulmonary disease
- Contrast-induced nephropathy prevention
- Various neuropsychiatric conditions (schizophrenia, bipolar disorder, OCD)
- Polycystic ovary disease and male infertility 5
NAC's mechanism of action in these conditions is primarily related to its antioxidant properties and ability to replenish glutathione stores, but these uses require further clinical validation before becoming standard practice.